BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31069155)

  • 1. Autoantibody status in systemic sclerosis patients defines both cancer risk and survival with ANA negativity in cases with concomitant cancer having a worse survival.
    Watad A; McGonagle D; Bragazzi NL; Tiosano S; Comaneshter D; Shoenfeld Y; Cohen AD; Amital H
    Oncoimmunology; 2019; 8(6):e1588084. PubMed ID: 31069155
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of anti-tubulin-α-1C autoantibody in systemic sclerosis].
    Zhao J; Sun F; Li Y; Zhao XZ; Xu D; Li YN; Li YH; Sun XL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1009-1013. PubMed ID: 33331306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended autoantibody panel in Turkish patients with early-stage systemic sclerosis: Coexpressions and their influences on clinical phenotypes.
    Temiz Karadağ D; Komac A; Erez Y; Birlik AM; Sari A; Akdoğan A; Farisogullari B; Kimyon G; Koc E; Arslan D; Karatas A; Koca SS; Kasifoglu N; Yazici A; Hayran KM; Cefle A
    Immun Inflamm Dis; 2023 Dec; 11(12):e1089. PubMed ID: 38134320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry.
    Hinchcliff M; Khanna S; Hsu VM; Lee J; Almagor O; Chang RW; Steen V; Chung L;
    Semin Arthritis Rheum; 2015 Dec; 45(3):309-14. PubMed ID: 26210782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to the Rpp25 component of the Th/To complex are the most common antibodies in patients with systemic sclerosis without antibodies detectable by widely available commercial tests.
    Mahler M; Satoh M; Hudson M; Baron M; Chan JY; Chan EK; Wick J; Fritzler MJ;
    J Rheumatol; 2014 Jul; 41(7):1334-43. PubMed ID: 24931955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis.
    Nihtyanova SI; Sari A; Harvey JC; Leslie A; Derrett-Smith EC; Fonseca C; Ong VH; Denton CP
    Arthritis Rheumatol; 2020 Mar; 72(3):465-476. PubMed ID: 31682743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Sclerosis is Linked to Psoriasis and May Impact on Patients' Survival: A Large Cohort Study.
    Watad A; Bragazzi NL; McGonagle D; Damiani G; Comaneshter D; Cohen A; Amital H
    J Clin Med; 2019 Apr; 8(4):. PubMed ID: 30995800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Autoantibodies and their clinical characteristics in systemic sclerosis].
    Hamaguchi Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(3):139-47. PubMed ID: 23812071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibody profiles associated with morbidity and mortality in scleroderma renal crisis.
    Tsuji H; Kuramoto N; Sasai T; Shirakashi M; Onizawa H; Kitagori K; Akizuki S; Nakashima R; Watanabe R; Onishi A; Murakami K; Yoshifuji H; Tanaka M; Hashimoto M; Ohmura K; Morinobu A
    Rheumatology (Oxford); 2022 Oct; 61(10):4130-4135. PubMed ID: 35078211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-PM-Scl antibody in patients with systemic sclerosis.
    Koschik RW; Fertig N; Lucas MR; Domsic RT; Medsger TA
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S12-6. PubMed ID: 22261302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between autoantibodies in systemic sclerosis and cancer in a national registry.
    Hoa S; Lazizi S; Baron M; Wang M; Fritzler MJ; Hudson M;
    Rheumatology (Oxford); 2022 Jul; 61(7):2905-2914. PubMed ID: 34599801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibody profile in a cohort of Algerian patients with systemic sclerosis.
    Tahiat A; Allam I; Abdessemed A; Mellal Y; Nebbab R; Ladjouze-Rezig A; Djidjik R
    Ann Biol Clin (Paris); 2020 Apr; 78(2):126-133. PubMed ID: 32175889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais.
    Foocharoen C; Watcharenwong P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R
    Int J Rheum Dis; 2017 Oct; 20(10):1572-1581. PubMed ID: 28296274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autoantibodies in systemic sclerosis and their clinical correlation in patients from a Midwestern region of Brazil].
    Coelho Horimoto AM; da Costa IP
    Rev Bras Reumatol; 2015; 55(3):229-39. PubMed ID: 25559063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting cardiopulmonary involvement in patients with systemic sclerosis: complementary value of nailfold videocapillaroscopy patterns and disease-specific autoantibodies.
    Markusse IM; Meijs J; de Boer B; Bakker JA; Schippers HPC; Schouffoer AA; Ajmone Marsan N; Kroft LJM; Ninaber MK; Huizinga TWJ; de Vries-Bouwstra JK
    Rheumatology (Oxford); 2017 Jul; 56(7):1081-1088. PubMed ID: 27940596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease-related autoantibody profile in patients with systemic sclerosis.
    Liaskos C; Marou E; Simopoulou T; Barmakoudi M; Efthymiou G; Scheper T; Meyer W; Bogdanos DP; Sakkas LI
    Autoimmunity; 2017 Nov; 50(7):414-421. PubMed ID: 28749191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a commercial immunoassay for autoantibodies in Chinese Han systemic sclerosis population.
    Liu C; Hou Y; Yang Y; Xu D; Li L; Li J; Wen X; Zeng X; Zhang F; Li Y
    Clin Chim Acta; 2019 Apr; 491():121-125. PubMed ID: 30685360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To what extent do autoantibodies help to identify high-risk patients in systemic sclerosis?
    Boonstra M; Mertens BJA; Bakker JA; Ninaber MK; Ajmone Marsan N; van der Helm-van Mil AHM; Scherer HU; Huizinga TWJ; de Vries-Bouwstra JK
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):109-117. PubMed ID: 30148428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis.
    Arora-Singh RK; Assassi S; del Junco DJ; Arnett FC; Perry M; Irfan U; Sharif R; Mattar T; Mayes MD
    J Autoimmun; 2010 Aug; 35(1):52-7. PubMed ID: 20223638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autoantibodies in systemic sclerosis: clinical interest and diagnosis approach].
    Admou B; Essaadouni L; Amal S; Arji N; Chabaa L; El Aouad R
    Ann Biol Clin (Paris); 2009; 67(3):273-81. PubMed ID: 19411229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.